rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Wendy Lynn Barnes

Director and Officer

Company insider

Files Form 4 as: Director and Officer, GoodRx Holdings.

In numbers

Trades disclosed
62
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
3 Mar 2025
Last trade
15 Oct 2026
Last filed
15 Oct 2026

Companies traded

Where they are an officer
GDRX GoodRx HoldingsDirector, Officer · Payments & Processors · last 15 Oct 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
15 Oct 2026filed 15 Oct 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code M—115,149filing
15 Oct 2026filed 15 Oct 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code F$169K50,021 at $3.38filing
15 Oct 2026filed 15 Oct 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code M—51,177filing
15 Oct 2026filed 15 Oct 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code F$75K22,232 at $3.38filing
15 Oct 2026filed 15 Oct 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code M—110,963filing
15 Oct 2026filed 15 Oct 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code F$163K48,203 at $3.38filing
15 Oct 2026filed 15 Oct 2026GDRX GoodRx Holdingsoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—115,149 at $0.00filing
15 Oct 2026filed 15 Oct 2026GDRX GoodRx Holdingsoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—51,177 at $0.00filing
15 Oct 2026filed 15 Oct 2026GDRX GoodRx Holdingsoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—110,963 at $0.00filing
15 Jul 2026filed 16 Jul 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code M—115,148filing
15 Jul 2026filed 16 Jul 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code F$151K50,021 at $3.01filing
15 Jul 2026filed 16 Jul 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code M—51,177filing
15 Jul 2026filed 16 Jul 2026GDRX GoodRx Holdingsoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—115,148 at $0.00filing
15 Jul 2026filed 16 Jul 2026GDRX GoodRx Holdingsoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—51,177 at $0.00filing
15 Jul 2026filed 16 Jul 2026GDRX GoodRx Holdingsoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—110,963 at $0.00filing
15 Jul 2026filed 16 Jul 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code F$67K22,232 at $3.01filing
15 Jul 2026filed 16 Jul 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code M—110,963filing
15 Jul 2026filed 16 Jul 2026GDRX GoodRx HoldingsPayments & ProcessorsSEC FORM 4 Code F$145K48,203 at $3.01filing
15 Jul 2026filed 16 Jul 2026GDRX GoodRx Holdingsoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—115,148 at $0.00filing
15 Jul 2026filed 16 Jul 2026GDRX GoodRx Holdingsoption or derivative · Payments & ProcessorsSEC FORM 4 Code M—51,177 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Justin FenglerOfficer · Officer at GoodRx Holdings, filing Form 4 there in the last year
Thomas (tc) ChanChief Accounting Officer · Chief Accounting Officer at GoodRx Holdings, filing Form 4 there in the last year
FRANCISCO PARTNERS IV, L.P.10% owner · 10% owner at GoodRx Holdings, filing Form 4 there in the last year
Christopher A. McGinnisOfficer · Officer at GoodRx Holdings, filing Form 4 there in the last year
Douglas Joseph HirschDirector · Director at GoodRx Holdings, filing Form 4 there in the last year